# Extracorporal Shock Wave Treatment to Improve Nerve Regeneration

> **NCT03147313** · NA · UNKNOWN · sponsor: **Ludwig Boltzmann Gesellschaft** · enrollment: 60 (estimated)

## Conditions studied

- Peripheral Nerve Injury

## Interventions

- **DEVICE:** MTS Medical UG Orthogold 100
- **DEVICE:** Sham

## Key facts

- **NCT ID:** NCT03147313
- **Lead sponsor:** Ludwig Boltzmann Gesellschaft
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-18
- **Primary completion:** 2023-04
- **Final completion:** 2023-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03147313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03147313, "Extracorporal Shock Wave Treatment to Improve Nerve Regeneration". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03147313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*